OPKO Health, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- OPKO Health, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-06-30 was 0.00 shares, a 100.00% decline year-over-year.
- OPKO Health, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-03-31 was 0.00 shares, a 100.00% decline year-over-year.
- OPKO Health, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-12-31 was 0.00 shares.
- OPKO Health, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-09-30 was 0.00 shares.
- OPKO Health, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 57.50K shares.
- OPKO Health, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 0.00 shares, a 100.00% decline from fiscal 2023.
- OPKO Health, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 18.75K shares, a 91.12% decline from fiscal 2022.
- OPKO Health, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 211.19K shares, a 52.59% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2026-06-30 | 0.00 shares 10-Q/A · filed 2026-08-28 | 0.00 shares derived: sum of 4 quarters · filed 2026-08-28 |
| 2026-03-31 | 0.00 shares 10-Q/A · filed 2026-08-28 | 1.25K shares derived: sum of 4 quarters · filed 2026-08-28 |
| 2025-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 57.50K shares 10-K · filed 2026-02-26 |
| 2025-09-30 | 0.00 shares 10-Q · filed 2025-10-29 | 57.50K shares derived: sum of 4 quarters · filed 2026-08-28 |
| 2025-06-30 | 1.25K shares 10-Q/A · filed 2026-08-28 | 57.50K shares derived: sum of 4 quarters · filed 2026-08-28 |
| 2025-03-31 | 56.25K shares 10-Q/A · filed 2026-08-28 | 56.25K shares derived: sum of 4 quarters · filed 2026-08-28 |
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 0.00 shares 10-K · filed 2026-02-26 |
| 2024-09-30 | 0.00 shares 10-Q · filed 2025-10-29 | 0.00 shares derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | 0.00 shares 10-Q · filed 2025-07-31 | 18.75K shares derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | 0.00 shares 10-Q · filed 2025-05-01 | 18.75K shares derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 18.75K shares 10-K · filed 2026-02-26 |
| 2023-09-30 | 18.75K shares 10-Q · filed 2024-11-07 | 18.75K shares derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | 0.00 shares 10-Q · filed 2024-08-07 | 27.75K shares derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | 0.00 shares 10-Q · filed 2024-05-07 | 574.09K shares derived: sum of 4 quarters · filed 2025-03-03 |
| 2022-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | 211.19K shares 10-K · filed 2025-03-03 |
| 2022-09-30 | 27.75K shares 10-Q · filed 2023-11-06 | |
| 2022-06-30 | 546.34K shares 10-Q · filed 2023-08-03 | |
| 2021-12-31 | 445.44K shares 10-K · filed 2024-03-01 | |
| 2020-12-31 | 206.88K shares 10-K · filed 2021-02-18 | |
| 2019-12-31 | 24.88K shares 10-K · filed 2020-03-02 | |
| 2018-12-31 | 540.00K shares 10-K · filed 2019-03-01 | |
| 2017-12-31 | 1.30M shares 8-K · filed 2019-01-29 | |
| 2016-12-31 | 1.84M shares 10-K · filed 2017-03-01 | |
| 2015-12-31 | 6.64M shares 10-K · filed 2016-02-29 | |
| 2014-12-31 | 2.72M shares 10-K · filed 2015-02-27 | |
| 2013-12-31 | 9.25M shares 10-K · filed 2014-03-03 | |
| 2012-12-31 | -1.02M shares 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |